Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood

Current Protocols in Immunology

Volumn , Issue SUPPL. 90, 2010, Pages

  Rådinger, Madeleine ^a   Jensen, Bettina M ^b   Kuehn, Hye Sun ^a   Kirshenbaum, Arnold ^b   Gilfillan, Alasdair M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Mental Health Services CPH   (Denmark)

Author keywords

CD34+ peripheral blood progenitor cells; Fc RI; HMC1 cells; human mast cells; KIT; LAD2 cells; mast cells

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; G PROTEIN COUPLED RECEPTOR; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TOLL LIKE RECEPTOR; TOLUIDINE DERIVATIVE;

CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL LINE; CELL POPULATION; CELL SELECTION; CELL SEPARATION; CELL TYPE; CRYOPRESERVATION; CULTURE MEDIUM; HEMATOPOIETIC STEM CELL; HUMAN; MAST CELL; MAST CELL DEGRANULATION; PRIORITY JOURNAL; REVIEW; STAINING;

BLOOD CELLS; CELL CULTURE TECHNIQUES; CELL LINE; CELL SEPARATION; FETAL BLOOD; HUMANS; MAST CELLS;

RODENTIA;

EID: 77956489518     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: 10.1002/0471142735.im0737s90     Document Type: Review

References (19)

1. Andersen, H.B., Holm, M., Hetland, T.E., Dahl, C., Junker, S., Schiotz, P.O., and, Hoffmann, H.J., 2008. Comparison of short term in vitro cultured human mast cells from different progenitors: Peripheral blood-derived progenitors generate highly mature and functional mast cells. J. Immunol. Methods 336: 166 - 174.
2. Butterfield, J.H., Weiler, D., Dewald, G., and, Gleich, G.J., 1988. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12: 345 - 355.
3. Furumoto, Y., Brooks, S., Olivera, A., Takagi, Y., Miyagishi, M., Taira, K., Casellas, R., Beaven, M.A., Gilfillan, A.M., and, Rivera, J., 2006. Cutting edge: Lentiviral short hairpin RNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival. J. Immunol. 176: 5167 - 5171.
4. Gilfillan, A.M., and, Tkaczyk, C., 2006. Integrated signaling pathways for mast-cell activation. Nat. Rev. Immunol. 6: 218 - 230.
5. Holm, M., Andersen, H.B., Hetland, T.E., Dahl, C., Hoffmann, H.J., Junker, S., and, Schiotz, P.O., 2008. Seven week culture of functional human mast cells from buffy coat preparations. J. Immunol. Methods 336: 213 - 221.
6. Iida, M., Matsumoto, K., Tomita, H., Nakajima, T., Akasawa, A., Ohtani, N.Y., Yoshida, N.L., Matsui, K., Nakada, A., Sugita, Y., Shimizu, Y., Wakahara, S., Nakao, T., Fujii, Y., Ra, C., and, Saito, H., 2001. Selective down-regulation of high-affinity IgE receptor (FcεRI) alpha-chain messenger RNA among transcriptome in cord blood-derived versus adult peripheral blood-derived cultured human mast cells. Blood 97: 1016 - 1022.
7. Jensen, B.M., Beaven, M.A., Iwaki, S., Metcalfe, D.D., and, Gilfillan, A.M., 2008. Concurrent inhibition of kit- and FcεRI-mediated signaling: Coordinated suppression of mast cell activation. J. Pharmacol. Exp. Ther. 324: 128 - 138.
8. Kirshenbaum, A.S., Goff, J.P., Semere, T., Foster, B., Scott, L.M., and, Metcalfe, D.D., 1999. Demonstration that human mast cells arise from a progenitor cell population that is CD34(), c-KIT(), and expresses aminopeptidase N (CD13). Blood 94: 2333 - 2342.
9. Kirshenbaum, A.S., Akin, C., Wu, Y., Rottem, M., Goff, J.P., Beaven, M.A., Rao, V.K., and, Metcalfe, D.D., 2003. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI. Leuk. Res. 27: 677 - 682. (Pubitemid 36683255)
10. Kraft, S., and, Kinet, J.P., 2007. New developments in FcεRI regulation, function and inhibition. Nat. Rev. Immunol. 7: 365 - 378.
11. Kuehn, H.S., and, Gilfillan, A.M., 2007. G protein-coupled receptors and the modification of FcεRI-mediated mast cell activation. Immunol. Lett. 113: 59 - 69.
12. Kuehn, H.S., Radinger, M., and, Gilfillan, A.M., 2010. Measuring mast cell mediator release. Curr. Protoc. Immunol. In press.
13. Mekori, Y.A., and, Metcalfe, D.D., 2000. Mast cells in innate immunity. Immunol. Rev. 173: 131 - 140.
14. Metcalfe, D.D., 2008. Mast cells and mastocytosis. Blood 112: 946 - 956.
15. Metcalfe, D.D., Baram, D., and, Mekori, Y.A., 1997. Mast cells. Physiol. Rev. 77: 1033 - 1079.
16. Qiao, H., Andrade, M.V., Lisboa, F.A., Morgan, K., and, Beaven, M.A., 2006. FcεR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 107: 610 - 618.
17. Rivera, J., and, Gilfillan, A.M., 2006. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 117: 1214 - 1225.
18. Ryzhov, S., Goldstein, A.E., Biaggioni, I., and, Feoktistov, I., 2006. Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells. Mol. Pharmacol. 70: 727 - 735.
19. Sundstrom, M., Vliagoftis, H., Karlberg, P., Butterfield, J.H., Nilsson, K., Metcalfe, D.D., and, Nilsson, G., 2003. Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-KIT proto-oncogene. Immunology 108: 89 - 97.